Total number of projects: 2
As coordinator: 0
As participant: 1
Sole participant: 1
Coordinator / Participant Ratio: 0*
Total project funding [€]: | Projects [No]: | |||||
---|---|---|---|---|---|---|
Year: | coordinator* | participant* | per partner | as coordinator | as participant | |
2022 | 2.500.000 | 0 | 2.500.000 | 1 | ||
2013 | 0 | 5.962.231 | 2.037.900 | 1 |
Total number of partners: 3
Partner loyalty:
Frequent Partner: (> 2 projects): 0
Rare Partner: 3
Frequent / Rare Partner Ratio: 0
Start date | Project | acronym | role | funding | partners |
---|---|---|---|---|---|
2022-09-01 | Inhibiting resistance to immunotherapy in Oncology by targeting Netrin-1 | ImmunoNet | coordinator | 2.500.000 | 1 |
2013-09-01 | First in Man Novel Anticancer Therapeutic based on Dependence Receptors Concept | HERMIONE-2MAN | participant | 5.962.231 | 4 |